Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sulkowski

Showing results (371-380 of 408) with videos related to

Pageof 41
Sort By:
Gastroenterology|August 21, 2010
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rateMark S Sulkowski, Mitchell L Shiffman, Nezam H Afdhal, et al.
Journal of Viral Hepatitis|October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesN H Afdhal, S Zeuzem, R T Schooley, et al.
Journal of Hepatology|June 30, 2026
A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C TrialSunil S Solomon, Aylur K Srikrishnan, Allison M McFall, et al.
Hepatology (Baltimore, Md.)|November 4, 2025
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis BMarc G Ghany, Calvin Q Pan, Anna S Lok, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplantMarion G Peters, Shyam Kottilil, Norah Terrault, et al.
Journal of Viral Hepatitis|July 17, 2020
Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in MarylandRisha Irvin, Boatemaa Ntiri-Reid, Mary Kleinman, et al.
Hepatology (Baltimore, Md.)|October 15, 2014
Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virusEric M Yoshida, Mark S Sulkowski, Edward J Gane, et al.
Gut|August 30, 2011
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3Alexander J Thompson, Keyur Patel, Wan-Long Chuang, et al.
The New England Journal of Medicine|April 12, 2014
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirinStefan Zeuzem, Ira M Jacobson, Tolga Baykal, et al.
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Pageof 41

Showing results (371-380 of 408) with videos related to

Sort By:
Pageof 41
Gastroenterology|August 21, 2010
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rateMark S Sulkowski, Mitchell L Shiffman, Nezam H Afdhal, et al.
Journal of Viral Hepatitis|October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesN H Afdhal, S Zeuzem, R T Schooley, et al.
Journal of Hepatology|June 30, 2026
A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C TrialSunil S Solomon, Aylur K Srikrishnan, Allison M McFall, et al.
Hepatology (Baltimore, Md.)|November 4, 2025
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis BMarc G Ghany, Calvin Q Pan, Anna S Lok, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 5, 2020
Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre- or post-liver transplantMarion G Peters, Shyam Kottilil, Norah Terrault, et al.
Journal of Viral Hepatitis|July 17, 2020
Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in MarylandRisha Irvin, Boatemaa Ntiri-Reid, Mary Kleinman, et al.
Hepatology (Baltimore, Md.)|October 15, 2014
Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virusEric M Yoshida, Mark S Sulkowski, Edward J Gane, et al.
Gut|August 30, 2011
Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3Alexander J Thompson, Keyur Patel, Wan-Long Chuang, et al.
The New England Journal of Medicine|April 12, 2014
Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirinStefan Zeuzem, Ira M Jacobson, Tolga Baykal, et al.
Gastroenterology|May 26, 2012
Factors that predict response of patients with hepatitis C virus infection to boceprevirFred Poordad, Jean-Pierre Bronowicki, Stuart C Gordon, et al.
Pageof 41